Willing to unlock the full value of your oncology innovation?
When applying to the MATWIN accelerating program, you will:
Assess and increase the potential of your project in the discovery / preclinical development phase from MATWIN’s coaching process
Obtain validation guidelines for your development plan (clinical strategy, indications, milestones, regulatory guidance etc.) from MATWIN International Board, experts in the field and KOLs
Get ready for the investment phase thanks to numerous individual high-added value coaching sessions
Optimize your partnership opportunities with biotechs / pharmas / investors
ELIGIBITY:
Open to European academic teams or start-ups
Preclinical or early clinical stages with validated POC and defined IP background
R&D oncology focused projects in therapeutic, diagnostic, medical device, technological platform, AI tools
